Board of the Pension Protection Fund purchased a new stake in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund purchased 2,100 shares of the semiconductor company's stock, valued at approximately $1,019,000. Synopsys comprises about 1.2% of Board of the Pension Protection Fund's investment portfolio, making the stock its 21st biggest position.
A number of other institutional investors have also added to or reduced their stakes in the stock. State Street Corp grew its holdings in Synopsys by 1.7% during the 3rd quarter. State Street Corp now owns 6,948,473 shares of the semiconductor company's stock worth $3,518,637,000 after acquiring an additional 119,057 shares during the last quarter. Geode Capital Management LLC raised its position in Synopsys by 1.9% during the 3rd quarter. Geode Capital Management LLC now owns 3,281,867 shares of the semiconductor company's stock worth $1,656,005,000 after purchasing an additional 61,799 shares during the last quarter. Edgewood Management LLC lifted its holdings in Synopsys by 18.9% during the 3rd quarter. Edgewood Management LLC now owns 3,069,848 shares of the semiconductor company's stock worth $1,554,540,000 after buying an additional 487,025 shares during the period. Van ECK Associates Corp grew its position in shares of Synopsys by 26.5% in the 3rd quarter. Van ECK Associates Corp now owns 1,605,001 shares of the semiconductor company's stock valued at $791,923,000 after buying an additional 335,993 shares during the last quarter. Finally, Parnassus Investments LLC acquired a new stake in shares of Synopsys in the third quarter valued at about $633,469,000. 85.47% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several analysts recently commented on the company. Mizuho started coverage on Synopsys in a report on Tuesday, October 22nd. They issued an "outperform" rating and a $650.00 target price on the stock. Loop Capital started coverage on shares of Synopsys in a research report on Monday, November 11th. They set a "buy" rating and a $675.00 price objective for the company. Redburn Atlantic began coverage on shares of Synopsys in a research note on Monday. They set a "buy" rating and a $600.00 target price for the company. Rosenblatt Securities reaffirmed a "buy" rating and set a $635.00 price target on shares of Synopsys in a research report on Wednesday, December 4th. Finally, Wells Fargo & Company lowered their price objective on Synopsys from $570.00 to $540.00 and set an "equal weight" rating for the company in a research report on Monday. One analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $641.82.
Read Our Latest Stock Analysis on Synopsys
Synopsys Trading Up 3.4 %
NASDAQ SNPS traded up $16.83 during mid-day trading on Wednesday, hitting $507.19. The company's stock had a trading volume of 1,129,094 shares, compared to its average volume of 1,010,197. The firm has a market capitalization of $78.40 billion, a price-to-earnings ratio of 34.93, a PEG ratio of 3.41 and a beta of 1.12. The company's 50 day simple moving average is $522.21 and its 200 day simple moving average is $527.43. Synopsys, Inc. has a twelve month low of $457.52 and a twelve month high of $629.38.
Synopsys Company Profile
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Recommended Stories
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.